tradingkey.logo

CeriBell Inc

CBLL
20.150USD
+0.810+4.19%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
746.53MCap. mercado
PérdidaP/E TTM

Más Datos de CeriBell Inc Compañía

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

Información de CeriBell Inc

Símbolo de cotizaciónCBLL
Nombre de la empresaCeribell Inc
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoChao (Xingjuan)
Número de empleados281
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 11
Dirección360 N. Pastoria Avenue
CiudadSUNNYVALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94085
Teléfono18004360826
Sitio Webhttps://ceribell.com/
Símbolo de cotizaciónCBLL
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoChao (Xingjuan)

Ejecutivos de CeriBell Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
Por negocioUSD
Nombre
Ganancia
Proporción
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
22.59M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%

Estadísticas de accionistas

Actualizado: hace 20 horas
Actualizado: hace 20 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Otro
58.67%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Otro
58.67%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
39.59%
Investment Advisor/Hedge Fund
20.38%
Private Equity
10.70%
Individual Investor
10.34%
Venture Capital
6.71%
Hedge Fund
4.41%
Research Firm
1.48%
Pension Fund
0.36%
Bank and Trust
0.21%
Otro
5.82%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
4.31M
11.63%
-376.91K
-8.04%
Sep 30, 2025
TPG Capital, L.P.
3.97M
10.7%
--
--
Sep 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.67%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.38%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
5.95%
--
--
Sep 30, 2025
Parvizi (Josef)
2.09M
5.64%
+6.62K
+0.32%
Apr 11, 2025
Ally Bridge Group (HK) Limited
1.69M
4.56%
-750.00K
-30.72%
Dec 09, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
4.09%
+146.63K
+10.70%
Sep 30, 2025
The Vanguard Group, Inc.
1.47M
3.97%
+147.01K
+11.09%
Sep 30, 2025
Chao (Xingjuan)
1.10M
2.96%
--
--
Dec 04, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Ver más
iShares Neuroscience and Healthcare ETF
Proporción0.57%
Hypatia Women CEO ETF
Proporción0.5%
Fidelity Fundamental Small-Mid Cap ETF
Proporción0.1%
iShares Micro-Cap ETF
Proporción0.06%
ProShares Hedge Replication ETF
Proporción0.02%
iShares Russell 2000 Growth ETF
Proporción0.02%
ProShares UltraPro Russell2000
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI